Research Publications:
1. Rahimian J, Bennett LR, Touya J, Akber SF. Metabolic lung scanning:
Demonstration of amine receptors with N-isopropyl-I-123-p-iodoamphetamine.
Clin Nucl Med 6:453, 1981.
2. Bennett LR, Akber SF, Touya J, Rahimian J and Graham LS. The feasibility
of metabolic lung scanning. J Nucl Med 23:49, 1982.
3. Rahimian J, Bennett LR, Glass EC, Graham LS, Akber SF, Tonya J
and Doria DM. Noninvasive determination by dual tracer deconvolution
analysis. Med Phys 9:714, 1982.
4. Rahimian J, Glass EC, Touya J, Akber SF, Graham LS, and Bennett
LR. Extraction fraction: Noninvasive determination by dual tracer
deconvolution analysis. Clin Nucl Med 7(9s):1, 1982.
5. Akber SF and Bennett LR. Influence of propranolol on the first
pass pulmonary extraction of N-isopropyl-I-123-piodoamphetamine. JIMA
16:19, 1984.
6. Akber SF, Bennett LR, Glass EC, Montgomery R and Rahimian J: Effects
of propranolol on the kinetics of N-isopropyl-I-123-piodoamphetamine.
Med Phys 13:742, 1984.
7. Akber SF, Glass EC, and Bennett LR. Scintigraphic demonstration
and quantitation iodoamphetamine of pharmacological inhibition of
pulmonary uptake of N-isopropyl-I-123p-by propranolol. J Nucl Med
26:14, 1985.
8. Akber SF. Noninvasive measurement of first pass pulmonary extraction
of N- Lakes Chapter of the Society of Nuclear Medicine, Niagara Falls,
Canada, May 13-14, 1986. iosoporopyl-I-123-piodoamphetamine in the
presence of Ketamine by dual tracer deconvolution analysis. Paper
presented at the 7th annual meeting of the Eastern Great
9. Akber SF. The enigma of relaxometry in biological systems. Proceedings
of the World Congress on Medical Physics and Biomedical Engineering.
Aug 6-12, 1988, San Antonio, Texas. Phys Med Biol 33:suppl 1, 63,
1988.
10. Karellas A, Akber SF, D'Orsi CJ, Kleinman PK and Davis MA. Novel
imaging technique to determine x-ray focal spot size of mammographic
systems with microchannel plate. Radiology 169(P):278, 1988.
11. Akber SF. A new index to assess water proton spin-lattice relaxation
times in normal rat tissue. Presented at the 32nd annual meeting of
the AAPM held at the Cervantes Convention Center, St. Louis, Missouri,
July 22-26, 1990.
12. Akber SF, Knesaurek K. Pulmonary biogenic amine uptake mechanism:
Is it dependent on pH, Lipophilicity or pka? Presented at the 5th
Congress World Federation of Nuclear Medicine & Biology, held
at Palais des Congress, Montreal, Canada on August 26-31, 1990.
13. Akber SF. An association between spin-lattice relaxation time
and organ mass. Med Phys 18:N9, 1991.
14. Akber SF, Wagner LK, Fang B. Screen sensitivity in mammography.
Paper presented at the SWAAPM Chapter Meeting, New Orleans, October
11-12, 1991.
15. Akber SF. Phototimer response in mammography. Paper presented
at the SWAAPM Chapter Meeting, Houston, Texas. April 2-3, 1992.
16. Akber SF. Screen sensitivity in mammography. Paper presented
at the 34th Annual meeting of the AAPM held in Calgary, Canada. July
1992.
17. Akber SF. Is water proton spin-lattice relaxation time independent
of species? Paper presented at the 34th Annual Meeting of the AAPM
held in Calgary, Canada. July 1992.
18. Akber SF. Automatic exposure control response in mammography.
Paper presented at the 34th Annual Meeting of the AAPM held in Calgary,
Canada. July 1992.
19. Akber SF. Is there a correlation between spin lattice relaxation
time and radiation sensitivity of human organs. Paper presented at
the 35th Annual Meeting of the AAPM held in Washington, D.C. August
1993.
20. Das IJ, Harrington JC, Akber SF, Tomer AF. Dosimetric problems
at low monitor unit settings for scanned and scattering foil electron
beams. Paper presented at the 35th Annual Meeting of the AAPM held
in Washington, D.C., August 1993.
21. Akber SF. Organ weight: A new perspective to assess spin lattice
relaxation time. Paper presented at the World Congress on Medical
Physics. Rio De Janeiro, Brazil. August 1994.
22. Akber SF. Screen sensitivity in mammography. Paper presented
at the World Congress on Medical Physics. Rio De Janeiro, Brazil.
August 1994.
23. Akber SF. A novel approach to assess spin lattice relaxation
time in normal rat tissues. (Paper presented at the 36th Annual meeting
of the AAPM. Anahiem. July 1994.) Medical Physics. 21, 956, 1994.
24. Akber SF. Screen Sensitivity in Mammography Paper presented at
North Central Chapter American Association of Physicists in Medicine.
Fall meeting. Marshfield, Wisconsin Friday, September 23, 1994.
25. Akber SF. A new index to assess spin lattice relaxation time.
AAPM. 1994
26. Akber SF. The effects of screen and cassette variations on automatic
exposure control performance in mammography. Paper presented at 7th
Asian and Oceanic Congress of Radiology. P. 188, June 1995.
27. Akber SF. The efficacy of paramagnetic ions on spin lattice relaxation
time in Biological systems. Paper presented at the 37th Annual meeting
of the American Association of physicists in Medicine. July 1995.
28. Akber SF and Das IJ. Ion recombination and polarity effects of
ionization chambers in x-ray exposure measurements. Paper presented
at the 38th Annual meeting of the American Association of physicists
in Medicine, Philadelphia. July 1996.
29. Akber SF. Tolerance dose assessment of normal human organs against
blood content. Paper to be presented at the World Congress on Medical
Physics and Biomedical Engineering. Nice, France. September 14- 19,
1997
30. Akber SF. Is TD50 correlated with organ weight? Paper presented
at North Central Chapter meeting of AAPM, University of Minnesota.
Nov. 3, 1997
31. Akber SF. A novel approach to assess tolerance dose of normal
human organs with organ weight, blood content and water proton spin
lattice relaxation time. Paper presented at RSNA, Chicago. Nov-Dec,
1997
32. Akber SF. A new perspective to assess mean lethal dose with organ
weight and water proton spin lattice relaxation time in human organs.
Paper presented at the 40th Annual Meeting of the AAPM, San Antonio,
1998
33. Akber SF. A common tissue parameter to assess water proton spin
lattice relaxation time in different species. Paper presented the
40th Annual Meeting of the AAPM, San Antonio, 1998.
34. Akber SF. Problems in Mammography. Presented at World congress
of Radiology, New Delhi, India, Sept. 1998.
35. Das IJ and Akber SF. Broad Beam attenuation of x-rays. Paper
presented at the 41st Annual Meeting of the AAPM, Nashville, Tennessee,
1999.
ARTICLES PUBLISHED OR ACCEPTED IN REFEREED JOURNALS:
1. Touya J, Akber SF, Rahimian J, and Bennett LR. Metaboliclung scanning
with N-isopropyl-I-123-p-idoamphetamine. In: Nuclear Medicine and
Biology Proceedings of the Third World Congress of Nuclear Medicine
and Biology. Raynaud C, ed. Paris, Pergamon Press III, 1982, pp 2554-2557.
2. Rahimian J, Glass EC, Touya JJ, Akber SF, Graham LS, and Bennett
LR. Measurement of Metabolic extraction of tracers in the lung using
a multiple indicator dilution technique. J Nucl Med 25:31-37, 1984.
3. Akber SF. Nuclear magnetic resonance medical imaging. JPMA 34:64-71,
1984.
4. Akber SF. Ketamine influence on the first pass pulmonaryextraction
of N-isopropyl-I-123-p-iodoamphetamine using indicator dilution technique.
Proceedings of the 14th International Conference on Medical Physics.
Espoo, Finland, August 11-16, 1985. Med Biol Engin Comput 23 (Suppl.
Part 2): 1377-1378, 1985.
5. Akber SF. Radionuclide imaging. JPMA 36:151-153, 1986.
6. Akber SF. The Lung as a metabolic organ. JPMA 36:132-134, 1986.
7. Akber SF. The Physics of NMR Tomography. Nuklearmedizin 25:33-37,
1986.
8. Akber SF. Pulmonary extraction of N-isopropyl-123-piodoampetamine
in the presence of propranolol using dual indicator dilution technique.
JIMA 18:34-37, 1986.
9. Akber SF. Clinical ramifications of iodine. Compr Ther 13:19-25,
1987.
10. Akber SF. On the theroy of the first pass pulmonary extraction
using indicator dilution technique. Nuklearmedizin 26:21-27, 1987.
11. Akber SF. Clinical ramifications of NMR imaging, Compr Ther 13:41-45,
1987.
12. Akber SF. A noninvasive assessment of pharmacological interaction
of amines in the lung. Nucl Med Commun 8:889893, 1987.
13. Akber SF. A comment on "A review of H-1 nuclear magnetic
resonance relaxation in pathology: Are T1 and T2 diagnostic?"
Med Phys 14:1090-1091, 1987.
14. Akber SF. The quagmire of relaxation times. Med Hypotheses 26:187-191,
1988.
15. Akber SF. The conumdrum of relaxation times. Nuklearmedizin 27:43-45,
1988.
16. Akber SF. Neutron Therapy: Of what clinical relevance? Compr
Ther 14:3-7, 1988.
17. Akber SF. Influence of anesthetics on relaxation times. Anesthesiology
69:290-291, 1988.
18. Akber SF. Correlation between oxygen tension and spinlattice
relaxation rate in tumors. Europ J Radiol 9:56-59, 1989.
19. Akber SF. Demonstration and quantitation of pharmacological inhibition
of pulmonary uptake of I-123IMP by propranolol. Nuklearmedizin 28:100-104,
1989.
20. Akber SF. A correlation between spin-lattice relaxtion time and
tumor growth. Europ J Radiol 9:198-199, 1989.
21. Akber SF. Physiological basis of spin-lattice relaxation time
in normal rat tissues. Proceeding 11th Annual Int'l Meeting IEEE in
Medicine and Biology. vol. II:Part 2/6:582583, 1989.
22. Akber SF. A pharmacokinetic approach to the determination of
pulmonary permeability. Proceeding 11th Annual Int'l Meeting IEEE
in Medicine and Biology. vol. II:Part 1/6:286-287, 1989.
23. Akber SF. Is there a correlation between spin-lattice relaxation
time and radiation sensitivity? Acta Radiologica 31:541-542, 1990.
24. Akber SF. Application of physics in medicine. JIMA 22:7279, 1990.
25. Akber SF. Scintigraphic demonstration and quantitation of pharmacological
assessment of I-123 IMP receptors in the lung. Ph.D. Thesis. University
of Zagreb, Yugoslavia, 1990.
26. Akber SF. Pulmonary biogenic amines uptake mechanism: Is it dependent
on pH, lipophilicity or pka? Nuclear Medicine 30:294-296, 1991.
27. Akber SF. A new perspective to assess relaxation time of tumor.
Med, Hypoth 37:24-26, 1992.
28. Akber SF. Paramagnetic ions influence on water proton spin lattice
relaxation times. PCP & Med NMR, 24:71-76, 1992.
29. Akber SF. Tumor-induced changes in the water proton spinlattice
relaxation times of brain tissues. PCP & Med NMR, 24:329-332,
1992.
30. Akber SF. Role of paramagnetic ions and water proton spin lattice
relaxation time in the biological systems. Nuclear Medicine 32:52-56,
1993.
31. Akber SF. A note on the influence of anesthetics on relaxation
times in biological system. PCP & Med NMR. 25:299-307, 1993.
32. Akber SF. Comment on "Contribution of paramagnetic trace
elements of biological tissues to spin-lattice relaxation times."
PCP & Med NMR -1994.
33. Akber SF. The relaxation efficacy of paramegnetic ions. PCP &
Med NMR - 1994.
34. Das IJ, Harrington JC, Akber SF, Tomer AF, Murray JC, Cheng CW.
Dosimetric Problems at low monitor unit-settings for scanned and scaltering
foil electron beams. Med Phys 21:821826 1994.
35. Akber SF. Is spin - lattice relaxation time independent of species.
Med Hypotheses 1995.
36. Akber SF. Is there a correlation between spin - lattice relaxation
time and radiation sensitivity of human organs. Med Hypotheses 1995.
44:469-470, 1995.
37. Akber SF. Centenary of Radiology. JPMA 1995
38. Akber SF. Automatic exposure control response in mammography.
Physica Medica 11:111-113, 1995
39. Akber SF. Screen sensitivity in mammography. Radiol Bras 29:65-68,
1996
40. Akber SF. Organ weight -- A new tissue parameter to assess water
proton spin - lattice relaxation time. Med Hypotheses 48:71-75, 1997
41. Akber SF. NMR relaxation data of water proton of normal tissues.
PCP and Med NMR 28: 205-238, 1996
42. Akber SF. Pulmonary metabolism of biogenic amines. Compr Therapy
23:254-258, 1997
43. Akber SF. NMR relaxation data of water proton of normal tissues.
PCP and Med NMR 28: 205-238, 1996
44. Akber SF. Pulmonary metabolism of biogenic amines. Compr Therapy
23:254- 258, 1997
45. Das IJ and Akber SF. Ion recombination and polarity effect of
ionization chambers inkilovoltage x-ray exposure measurements. Med
Phys 25:1751-1757, 1998
46. Akber SF. The clinical efficacy of paramagnetic ion in the biological
systems. PCP and Medical NMR. 30: 175-184, 1998
47. Akber SF. Is TD50 correlated with organ weight? American J Clinical
Oncology 22: 534-535, 1999.
48. Das IJ. Cheng CW. Akber SF. Low monitor units: significance in
special therapy. Physics in Medicine & Biology. 44(2):LI-2, 1999.
49. Akber SF. X-rays in the service of humanity. JIMA 1999.
50. Akber SF. Breast cancer imaging modality. JIMA 31; 281-285, 1999
51. Akber SF. Correlation between Radiation tolerance dose of normal
human organ with organ weight, blood and water content. Am J Clinical
Oncology. 23:104-105, 2000
52. Akber SF. Correlation between water proton spin lattice relaxation
time and radiation tolerance dose in normal human tissues. Am J Clin
Oncology. 23:345-349, 2000.